Biotech Financier Frederick Frank Delivers Keynote Address at 12th Annual C21 BioVentures Conference
June 1, 2010 by biotechcheck.com · Leave a Comment
Biotech Financier Frederick Frank Delivers Keynote Address at 12th Annual C21 BioVentures Conference
NAPA, Calif.—-Frederick Frank, Vice Chairman and Co-Head of the global pharmaceutical and life sciences practices of Peter J. Solomon Company, offered his insights into the changing landscape and future direction of the biotechnology and pharmaceutical industries in a keynote address today at the 12th Annual C21 BioVentures Conference in Napa, California.
Read more on Business Wire via Yahoo! Finance
Vatican, biotech firm to work together to educate on adult stem cells
June 1, 2010 by biotechcheck.com · Leave a Comment
Vatican, biotech firm to work together to educate on adult stem cells
WASHINGTON (CNS) — Foundations affiliated with the Pontifical Council for Culture and an international biopharmaceutical company will work together to educate Catholics and others around the world about the benefits of adult stem-cell research.
Read more on Catholic News Service
Biotech co Kamada gets sales OK in Russia
June 1, 2010 by biotechcheck.com · Leave a Comment
Biotech co Kamada gets sales OK in Russia
The drug will be marketed under the name “RespiKam”.
Read more on Globes Online
Panel advises tech startups on SBA loans
May 31, 2010 by biotechcheck.com · Leave a Comment
Panel advises tech startups on SBA loans
With the credit crunch lingering, local entrepreneurs still face a battle getting commercial loans. But the federal stimulus package is making it easier for them to get loans from the Small Business Administration, a panel of local lenders and business executives said Tuesday at a seminar sponsored by Connect, a San Diego organization that supports high-tech and biotech businesses.
Read more on San Diego Union-Tribune
Biotech Stocks: Javelin shares plunge on U.K. drug recall
May 31, 2010 by biotechcheck.com · Leave a Comment
Biotech Stocks: Javelin shares plunge on U.K. drug recall
Shares of Javelin Pharmaceuticals plunge after the company announces its European commercial partner was recalling all batches of its pain medication Dyloject from the U.K. market due to quality control problems.
Read more on Market Watch


